Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:428362rdf:typepubmed:Citationlld:pubmed
pubmed-article:428362lifeskim:mentionsumls-concept:C0019944lld:lifeskim
pubmed-article:428362lifeskim:mentionsumls-concept:C0004477lld:lifeskim
pubmed-article:428362lifeskim:mentionsumls-concept:C0233571lld:lifeskim
pubmed-article:428362lifeskim:mentionsumls-concept:C0013125lld:lifeskim
pubmed-article:428362pubmed:issue1lld:pubmed
pubmed-article:428362pubmed:dateCreated1979-6-26lld:pubmed
pubmed-article:428362pubmed:abstractTextThe rapid intravenous administration of the butyrophenone tranquilliser, azaperone, at a dose rate of 0.29-0.57 mg/kg body weight resulted in the immediate onset of excitement and ataxia of varying degree in over half the animals. The severity of the reaction appeared to be related to the size of the animal. Other side effects such as salivation, sweating, muscle tremor and vocalisation were also observed. The possible causes of this paradoxical reaction to the tranquilliser are discussed.lld:pubmed
pubmed-article:428362pubmed:languageenglld:pubmed
pubmed-article:428362pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:428362pubmed:citationSubsetIMlld:pubmed
pubmed-article:428362pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:428362pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:428362pubmed:statusMEDLINElld:pubmed
pubmed-article:428362pubmed:monthJanlld:pubmed
pubmed-article:428362pubmed:issn0425-1644lld:pubmed
pubmed-article:428362pubmed:authorpubmed-author:DodmanN HNHlld:pubmed
pubmed-article:428362pubmed:authorpubmed-author:WatermanA EAElld:pubmed
pubmed-article:428362pubmed:issnTypePrintlld:pubmed
pubmed-article:428362pubmed:volume11lld:pubmed
pubmed-article:428362pubmed:ownerNLMlld:pubmed
pubmed-article:428362pubmed:authorsCompleteYlld:pubmed
pubmed-article:428362pubmed:pagination33-5lld:pubmed
pubmed-article:428362pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-A...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-I...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-H...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-A...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-H...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-F...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-M...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-H...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-B...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-P...lld:pubmed
pubmed-article:428362pubmed:meshHeadingpubmed-meshheading:428362-A...lld:pubmed
pubmed-article:428362pubmed:year1979lld:pubmed
pubmed-article:428362pubmed:articleTitleParadoxical excitement following the intravenous administration of azaperone in the horse.lld:pubmed
pubmed-article:428362pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:428362pubmed:publicationTypeComparative Studylld:pubmed